118 related articles for article (PubMed ID: 6152321)
1. Probes for narcotic receptor mediated phenomena. 10. Irreversible ligands to opioid receptors based on biologically potent endoethenooripavines. Reversible binding of fit to mu and delta opioid receptors.
Lessor RA; Rice KC; Streaty RA; Klee WA; Jacobson AE
Neuropeptides; 1984 Dec; 5(1-3):229-32. PubMed ID: 6152321
[TBL] [Abstract][Full Text] [Related]
2. Probes for narcotic receptor mediated phenomena. 13. Potential irreversible narcotic antagonist-based ligands derived from 6,14-endo-ethenotetrahydronororipavine with 7-(methoxyfumaroyl)amino, (bromoacetyl)amino, or isothiocyanate electrophiles: chemistry, biochemistry, and pharmacology.
Lessor RA; Bajwa BS; Rice KC; Jacobson AE; Streaty RA; Klee WA; Smith CB; Aceto MD; May EL; Harris LS
J Med Chem; 1986 Nov; 29(11):2136-41. PubMed ID: 3023609
[TBL] [Abstract][Full Text] [Related]
3. Probes for narcotic receptor mediated phenomena. 7. Synthesis and pharmacological properties of irreversible ligands specific for mu or delta opiate receptors.
Burke TR; Bajwa BS; Jacobson AE; Rice KC; Streaty RA; Klee WA
J Med Chem; 1984 Dec; 27(12):1570-4. PubMed ID: 6150112
[TBL] [Abstract][Full Text] [Related]
4. Irreversible ligands with high selectivity toward delta and mu opiate receptors.
Rice KC; Jacobson AE; Burke TR; Bajwa BS; Streaty RA; Klee WA
Science; 1983 Apr; 220(4594):314-6. PubMed ID: 6132444
[TBL] [Abstract][Full Text] [Related]
5. Mu-, delta- and kappa-opioid receptor-mediated inhibition of neurotransmitter release and adenylate cyclase activity in rat brain slices: studies with fentanyl isothiocyanate.
Schoffelmeer AN; Rice KC; Jacobson AE; Van Gelderen JG; Hogenboom F; Heijna MH; Mulder AH
Eur J Pharmacol; 1988 Sep; 154(2):169-78. PubMed ID: 2906610
[TBL] [Abstract][Full Text] [Related]
6. Probes for narcotic receptor mediated phenomena. 12. cis-(+)-3-Methylfentanyl isothiocyanate, a potent site-directed acylating agent for delta opioid receptors. Synthesis, absolute configuration, and receptor enantioselectivity.
Burke TR; Jacobson AE; Rice KC; Silverton JV; Simonds WF; Streaty RA; Klee WA
J Med Chem; 1986 Jun; 29(6):1087-93. PubMed ID: 3012085
[TBL] [Abstract][Full Text] [Related]
7. Differential coupling of mu-competitive and mu-noncompetitive delta opiate receptors to guanine nucleotide binding proteins in rat brain membranes.
Bowen WD; Rodrigues PA; Wanzor TE; Jacobson AE; Rice KC
Biochem Pharmacol; 1988 Feb; 37(3):467-72. PubMed ID: 2827687
[TBL] [Abstract][Full Text] [Related]
8. Fentanyl isothiocyanate reveals the existence of physically associated mu- and delta-opioid receptors mediating inhibition of adenylate cyclase in rat neostriatum.
Schoffelmeer AN; Rice KC; Heijna MH; Hogenboom F; Mulder AH
Eur J Pharmacol; 1988 Apr; 149(1-2):179-82. PubMed ID: 2840299
[TBL] [Abstract][Full Text] [Related]
9. Analgesic activity and opioid receptor selectivity of stereoisomers of ohmefentanyl isothiocyanate.
Chen BY; Jin WQ; Chen XJ; Zhu YC; Chi ZQ
Eur J Pharmacol; 2001 Jul; 424(3):195-8. PubMed ID: 11672562
[TBL] [Abstract][Full Text] [Related]
10. Interaction of peptides and morphine-like narcotic analgesics with specifically labelled mu- and delta-opiate receptor binding sites.
Hermans B; Gommeren W; De Potter WP; Leysen JE
Arch Int Pharmacodyn Ther; 1983 Jun; 263(2):317-9. PubMed ID: 6136260
[No Abstract] [Full Text] [Related]
11. 14 beta-(Bromoacetamido)morphine irreversibly labels mu opioid receptors in rat brain membranes.
Bidlack JM; Frey DK; Seyed-Mozaffari A; Archer S
Biochemistry; 1989 May; 28(10):4333-9. PubMed ID: 2548575
[TBL] [Abstract][Full Text] [Related]
12. Probes for narcotic receptor mediated phenomena. 5. Narcotic antagonist irreversible ligands based on endoethenotetrahydrooripavine.
Jacobson AE; Bajwa BS; Streaty RA; Klee WA; Rice KC
Life Sci; 1983; 33 Suppl 1():159-62. PubMed ID: 6319854
[TBL] [Abstract][Full Text] [Related]
13. Probes for narcotic receptor mediated phenomena. 15. (3S,4S)-(+)-trans-3-methylfentanyl isothiocyanate, a potent site-directed acylating agent for the delta opioid receptors in vitro.
Kim CH; Rothman RB; Jacobson AE; Mattson MV; Bykov V; Streaty RA; Klee WA; George C; Long JB; Rice KC
J Med Chem; 1989 Jun; 32(6):1392-8. PubMed ID: 2542560
[TBL] [Abstract][Full Text] [Related]
14. Evidence that the delta-selective alkylating agent, fit, alters the mu-noncompetitive opiate delta binding site.
Rothman RB; Danks JA; Herkenham M; Jacobson AE; Burke TR; Rice KC
Neuropeptides; 1985 Jun; 6(3):227-37. PubMed ID: 2991807
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
[TBL] [Abstract][Full Text] [Related]
16. Affinity labeling of mu opioid receptors by sulfhydryl alkylating derivatives of morphine and morphinone.
Bidlack JM; Frey DK; Kaplan RA; Seyed-Mozaffari A; Archer S
Mol Pharmacol; 1990 Jan; 37(1):50-9. PubMed ID: 1688995
[TBL] [Abstract][Full Text] [Related]
17. A study of the interaction of the alkylating agent, NIH10236, with opioid receptors in vitro and in vivo.
Rothman RB; Long JB; Holaday JW; Bykov V; de Costa BR; Kim CH; Jacobson AE; Rice KC
Neuropharmacology; 1989 Dec; 28(12):1349-56. PubMed ID: 2559348
[TBL] [Abstract][Full Text] [Related]
18. In vivo binding of putative delta-selective opioid antagonists to central opiate receptors.
Richards ML; Sadeé W
Eur J Pharmacol; 1986 Jul; 126(3):313-6. PubMed ID: 3019718
[TBL] [Abstract][Full Text] [Related]
19. [3H]ohmefentanyl preferentially binds to mu-opioid receptors but also labels sigma-sites in rat brain sections.
Wang H; Pélaprat D; Roques BP; Vanhove A; Chi ZQ; Rostène W
Eur J Pharmacol; 1991 Feb; 193(3):341-50. PubMed ID: 1647320
[TBL] [Abstract][Full Text] [Related]
20. Mu opiate receptors are selectively labelled by [3H]carfentanil in human and rat brain.
Titeler M; Lyon RA; Kuhar MJ; Frost JF; Dannals RF; Leonhardt S; Bullock A; Rydelek LT; Price DL; Struble RG
Eur J Pharmacol; 1989 Aug; 167(2):221-8. PubMed ID: 2556284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
